Prevalence and control of hypertension in the general practice in Italy: Updated analysis of a large database

Journal of Human Hypertension

Volumn 31, Issue 4, 2017, Pages 258-262

  Tocci, G ^a,b   Nati, G ^c   Cricelli, C ^c   Parretti, D ^c   Lapi, F ^d   Ferrucci, A ^a   Borghi, C ^e   Volpe, M ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

^c Società Italiana di Medicina Generale SIMG   (Italy)

^d Italian College of General Practitioners   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE REGULATION; DATA BASE; DIASTOLIC BLOOD PRESSURE; FEMALE; GENERAL PRACTICE; HUMAN; HYPERTENSION; ITALY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTPATIENT; PREVALENCE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; VERY ELDERLY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENERAL PRACTICE; HUMANS; HYPERTENSION; ITALY; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 84987651014     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2016.71     Document Type: Article

References (38)

1. Whyte JL, Lapuerta P, L'Italien GJ, Franklin SS. The challenge of controlling systolic blood pressure: data from the National Health and Nutrition Examination Survey (NHANES III), 1988-1994. J Clin Hypertens (Greenwich) 2001; 3 (4): 211-216.
2. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43 (1): 10-17.
3. Bramlage P, Bohm M, Volpe M, Khan BV, Paar WD, Tebbe U et al. A global perspective on blood pressure treatment and control in a referred cohort of hypertensive patients. J Clin Hypertens (Greenwich) 2010; 12 (9): 666-677.
4. Prugger C, Keil U, Wellmann J, de Bacquer D, de Backer G, Ambrosio GB et al. Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: results from the EUROASPIRE III survey. J Hypertens 2011; 29 (8): 1641-1648.
5. Dallongeville J, Banegas JR, Tubach F, Guallar E, Borghi C, De Backer G et al. Survey of physicians' practices in the control of cardiovascular risk factors: the EURIKA study. Eur J Prev Cardiol 2012; 19 (3): 541-550.
6. Volpe M, Tocci G, Trimarco B, Rosei EA, Borghi C, Ambrosioni E et al. Blood pressure control in Italy: results of recent surveys on hypertension. J Hypertens 2007; 25 (7): 1491-1498.
7. Tocci G, Rosei EA, Ambrosioni E, Borghi C, Ferri C, Ferrucci A et al. Blood pressure control in Italy: analysis of clinical data from 2005-2011 surveys on hypertension. J Hypertens 2012; 30 (6): 1065-1074.
8. Tocci G, Ferrucci A, Pontremoli R, Ferri C, Rosei EA, Morganti A et al. Blood pressure levels and control in Italy: comprehensive analysis of clinical data from 2000-2005 and 2005-2011 hypertension surveys. J Hum Hypertens 2015; 29 (11): 696-701.
9. Filippi A, Paolini I, Innocenti F, Mazzaglia G, Battaggia A, Brignoli O. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice. J Hum Hypertens 2009; 23 (11): 758-763.
10. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31 (7): 1281-1357.
11. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311 (5): 507-520.
12. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004; 18 (3):139-185.
13. Volpe M. The changing role of hypertension societies: shifting gears in Italy. High Blood Press Cardiovasc Prev 2012; 19 (1): 1-2.
14. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288 (23): 2981-2997.
15. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348 (5): 383-393.
16. Mohan S, Campbell NR. Hypertension management: time to shift gears and scale up national efforts. Hypertension 2009; 53 (3): 450-451.
17. Campbell NR, Brant R, Johansen H, Walker RL, Wielgosz A, Onysko J et al. Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada. Hypertension 2009; 53 (2): 128-134.
18. Falaschetti E, Campbell NR, Mohan S, Poulter N. Implementation of pay for performance policy in England. Hypertension 2009; 54 (1): e5.
19. Feldman RD, Zou GY, Vandervoort MK, Wong CJ, Nelson SA, Feagan BG. A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial. Hypertension 2009; 53 (4): 646-653.
20. Mourad JJ, Girerd X. Objective for 2015: 70% of treated and controlled hypertensive patients. Seven key points to reach this goal in practice. A joint call for action of the French League against hypertension and the French Society of Hypertension. J Mal Vasc 2012; 37 (6): 295-299.
21. Filippi A, Bignamini AA, Sessa E, Samani F, Mazzaglia G. Secondary prevention of stroke in Italy: a cross-sectional survey in family practice. Stroke 2003; 34 (4): 1010-1014.
22. Cricelli C, Mazzaglia G, Samani F, Marchi M, Sabatini A, Nardi R et al. Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases. J Public Health Med 2003; 25 (3): 254-257.
23. Filippi A, Sangiorgi D, Buda S, Degli Esposti L, Nati G, Paolini I et al. How many hypertensive patients can be controlled in 'real life': an improvement strategy in primary care. BMC Fam Pract 2013; 14: 192.
24. Danaei G, Finucane MM, Lin JK, Singh GM, Paciorek CJ, Cowan MJ et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet 2011; 377 (9765): 568-577.
25. Filippi A, Degli Esposti L, Buda S, Diguardo A, Paolini I, Nati G. Why is my hypertensive patient still not controlled? High Blood Press Cardiovasc Prev 2015; 22(1): 69-72.
26. Palmieri L, Panico S, Vanuzzo D, Ferrario M, Pilotto L, Sega R et al. [Evaluation of the global cardiovascular absolute risk: the Progetto CUORE individual score]. Annali dell'Istituto superiore di sanita 2004; 40 (4): 393-399.
27. Mancia G, Bombelli M, Lanzarotti A, Grassi G, Cesana G, Zanchetti A et al. Systolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni. Arch Intern Med 2002; 162 (5): 582-586.
28. Borghi C, Dormi A, D'Addato S, Gaddi A, Ambrosioni E. Brisighella Heart Study Working Party Trends in blood pressure control and antihypertensive treatment in clinical practice: the Brisighella Heart Study. J Hypertens 2004; 22 (9): 1707-1716.
29. Mancia G, Ambrosioni E, Rosei EA, Leonetti G, Trimarco B, Volpe M. Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: results of the ForLife study. J Hypertens 2005; 23 (8):1575-1581.
30. Manuel DG, Lim J, Tanuseputro P, Anderson GM, Alter DA, Laupacis A et al. Revisiting Rose: strategies for reducing coronary heart disease. BMJ 2006; 332 (7542): 659-662.
31. Tocci G, De Luca N, Sarzani R, Ambrosioni E, Borghi C, Cottone S et al. National survey on excellence centers and reference centers for hypertension diagnosis and treatment: geographical distribution, medical facilities and diagnostic opportunities. High Blood Press Cardiovasc Prev 2014; 21 (1): 29-36.
32. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011; 123 (8): 933-944.
33. Unal B, Critchley JA, Capewell S. Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention. BMJ 2005; 331 (7517): 614.
34. Volpe M, Rosei EA, Ambrosioni E, Cottone S, Cuspidi C, Borghi C et al. Renal artery denervation for treating resistant hypertension: definition of the disease, patient selection and description of the procedure. High Blood Press Cardiovasc Prev 2012; 19 (4): 237-244.
35. Volpe M, Rosei EA, Ambrosioni E, Cottone S, Cuspidi C, Borghi C et al. 2012 consensus document of the Italian Society of Hypertension (SIIA): strategies to improve blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy. High Blood Press Cardiovasc Prev 2013; 20 (1): 45-52.
36. Volpe M, de la Sierra A, Kreutz R, Laurent S, Manolis AJ. ARB-based single-pill platform to guide a practical therapeutic approach to hypertensive patients. High Blood Press Cardiovasc Prev 2014; 21 (2): 137-147.
37. Zanchetti A, Facchetti R, Cesana GC, Modena MG, Pirrelli A, Sega R et al. Menopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological study. J Hypertens 2005; 23 (12): 2269-2276.
38. Wall HK, Hannan JA, Wright JS. Patients with undiagnosed hypertension: hiding in plain sight. JAMA 2014; 312 (19): 1973-1974.